» Articles » PMID: 33588442

Diagnostic Pathology of Tumors of Peripheral Nerve

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 2021 Feb 15
PMID 33588442
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Neoplasms of the peripheral nervous system represent a heterogenous group with a wide spectrum of morphological features and biological potential. They range from benign and curable by complete excision (schwannoma and soft tissue perineurioma) to benign but potentially aggressive at the local level (plexiform neurofibroma) to the highly malignant (malignant peripheral nerve sheath tumors [MPNST]). In this review, we discuss the diagnostic and pathologic features of common peripheral nerve sheath tumors, particularly those that may be encountered in the intracranial compartment or in the spine and paraspinal region. The discussion will cover schwannoma, neurofibroma, atypical neurofibromatous neoplasms of uncertain biological potential, intraneural and soft tissue perineurioma, hybrid nerve sheath tumors, MPNST, and the recently renamed enigmatic tumor, malignant melanotic nerve sheath tumor, formerly referred to as melanotic schwannoma. We also discuss the diagnostic relevance of these neoplasms to specific genetic and familial syndromes of nerve, including neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis. In addition, we discuss updates in our understanding of the molecular alterations that represent key drivers of these neoplasms, including neurofibromatosis type 1 and type 2, SMARCB1, LZTR1, and PRKAR1A loss, as well as the acquisition of CDKN2A/B mutations and alterations in the polycomb repressor complex members (SUZ12 and EED) in the malignant progression to MPNST. In summary, this review covers practical aspects of pathologic diagnosis with updates relevant to neurosurgical practice.

Citing Articles

Cerebrospinal fluid dissemination of an intracranial malignant peripheral nerve sheath tumor in the sellar region: illustrative case.

Li T, Xiao S, Sun M, Wu Z, Guo J, Xing Y J Neurosurg Case Lessons. 2025; 9(9).

PMID: 40030145 PMC: 11877366. DOI: 10.3171/CASE24437.


Atypical Pelvic Tumors in Children.

Sobieraj P, Bekiesinska-Figatowska M Cancers (Basel). 2025; 17(4).

PMID: 40002214 PMC: 11853632. DOI: 10.3390/cancers17040619.


Hybrid peripheral nerve sheath tumours - A Review.

Chaturvedi H, Chaturvedi C J Oral Maxillofac Pathol. 2025; 28(4):651-656.

PMID: 39949689 PMC: 11819630. DOI: 10.4103/jomfp.jomfp_126_24.


Schwannoma in the lower inner quadrant of the right breast in a male patient: A rare case report.

Chen J, Huang Y, Liu H, Sun Y, Liu F Medicine (Baltimore). 2025; 104(5):e41309.

PMID: 39889177 PMC: 11789902. DOI: 10.1097/MD.0000000000041309.


Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.

Ortega-Bertran S, Fernandez-Rodriguez J, Magallon-Lorenz M, Zhang X, Creus-Bachiller E, Diazgranados A Clin Cancer Res. 2025; 31(5):907-920.

PMID: 39786423 PMC: 11873804. DOI: 10.1158/1078-0432.CCR-24-2807.


References
1.
Woodruff J, Godwin T, Erlandson R, Susin M, Martini N . Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol. 1981; 5(8):733-44. View

2.
Miettinen M, Antonescu C, Fletcher C, Kim A, Lazar A, Quezado M . Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol. 2017; 67:1-10. PMC: 5628119. DOI: 10.1016/j.humpath.2017.05.010. View

3.
Wang L, Zehir A, Sadowska J, Zhou N, Rosenblum M, Busam K . Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP-array and next generation sequencing analysis. Genes Chromosomes Cancer. 2015; 54(8):463-471. PMC: 6446921. DOI: 10.1002/gcc.22254. View

4.
Pemov A, Hansen N, Sindiri S, Patidar R, Higham C, Dombi E . Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Neuro Oncol. 2019; 21(8):981-992. PMC: 6682216. DOI: 10.1093/neuonc/noz028. View

5.
Pekmezci M, Reuss D, Hirbe A, Dahiya S, Gutmann D, von Deimling A . Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Mod Pathol. 2014; 28(2):187-200. PMC: 6816504. DOI: 10.1038/modpathol.2014.109. View